Direct Determination of the Primary Binding Site of Cisplatin on Cytochrome c by Mass Spectrometry

Journal of the American Society for Mass Spectrometry

Volumn 20, Issue 6, 2009, Pages 1141-1147

  Zhao, Ting ^a   King, Fred L ^a  

^a WEST VIRGINIA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; CYTOCHROME C; DIRECT DETERMINATIONS; FOURIER TRANSFORM MASS SPECTROMETRIES; ION SPECTRUM; MODEL PROTEINS; MOLECULAR LEVELS; PEPTIDE BONDS; PRIMARY BINDING SITES; SIDE EFFECTS; TANDEM MASS SPECTROMETRIES; THERAPEUTIC AGENTS; TRYPSIN DIGESTIONS;

AMINES; BINDING ENERGY; MASS SPECTROMETERS; MASS SPECTROMETRY; PEPTIDES; PLATINUM; PLATINUM COMPOUNDS; PORPHYRINS; SPECTRUM ANALYSIS;

BINDING SITES;

CISPLATIN; CYTOCHROME C; PEPTIDE; TRYPSIN;

ARTICLE; BINDING SITE; DIGESTION; DRUG PROTEIN BINDING; FOURIER TRANSFORM MASS SPECTROMETRY; MASS SPECTROMETRY; TANDEM MASS SPECTROMETRY;

ANIMALS; BINDING SITES; CISPLATIN; CYTOCHROMES C; FOURIER ANALYSIS; HORSES; MASS SPECTROMETRY; METHIONINE; TRYPSIN;

EID: 65549096295     PISSN: 10440305     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jasms.2009.02.013     Document Type: Article

References (31)

1. Jamieson E.R., and Lippard S.J. Structure, recognition, and processing of cisplatin-DNA adducts. Chem. Rev. 99 (1999) 2467-2498
2. Lippert B. Cisplatin: Chemistry and Biochemistry of a Leading Anticancer Drug (1999), Wiley-VCH, New York
3. Hickman J.A. Apoptosis induced by anticancer drugs. Cancer Metast. Rev. 11 (1992) 121-139
4. Hurley L.H., and Boyd F.L. DNA as a target for drug action. Trends Pharmacol. Sci. 9 (1988) 402-407
5. DeConti R.C., Toftness B.R., Lange R.C., and Creasey W.A. Clinical and pharmacological studies with cis-diamminedichloroplatinum (II). Cancer Res. 33 (1973) 1310-1315
6. Timerbaev A.R., Hartinger C.G., Aleksenko S.S., and Keppler B.K. Interactions of antitumor metallodrugs with serum proteins: Advances in characterization using modern analytical methodology. Chem. Rev. 106 (2006) 2224-2248
7. Appleton T.G. Donor atom preferences in complexes of platinum and palladium with amino acids and related molecules. Coord. Chem. Rev. 166 (1997) 313-359
8. Ivanov A.I., Christodoulou J., Parkinson J.A., Barnham K.J., Tucker A., Woodrow J., and Sadler P.J. Cisplatin binding sites on human albumin. J. Biol. Chem. 273 (1998) 14721-14730
9. 2. J. Inorg. Biochem. 65 (1997) 73-77
10. Calderone V., Casini A., Mangani S., Messori L., and Orioli P.L. Structural investigation of cisplatin-protein interactions: Selective platination of His19 in a cuprozinc superoxide dismutase. Angew. Chem. Int. Ed. 45 (2006) 1267-1269
11. Casini A., Mastrobuoni G., Temperini C., Gabbiani C., Francese S., Moneti G., Supuran C.T., Scozzafava A., and Messori L. ESI mass spectrometry and X-ray diffraction studies of adducts between anticancer platinum drugs and hen egg white lysozyme. Chem. Commun. 2 (2007) 156-158
12. Heck A.J.R., and Van Den Heuvel R.H.H. Investigation of intact protein complexes by mass spectrometry. Mass Spectrom. Rev. 23 (2004) 368-389
13. Loo J.A. Studying noncovalent protein complexes by electrospray ionization mass spectrometry. Mass Spectrom. Rev. 16 (1997) 1-23
14. Carr S.A., Annan R.S., and Huddleston M.J. Mapping post-translational modifications of proteins by MS-based selective detection: application to phosphoproteomics. Methods Enzymol. 405 (2005) 82-115
15. Gibson D., and Costello C.E. A mass spectral study of the binding of the anticancer drug cisplatin to ubiquitin. Eur. Mass Spectrom. 5 (1999) 501-510
16. Peleg-Shulman T., and Gibson D. Cisplatin-protein adducts are efficiently removed by glutathione but not by 5′-guanosine monophosphate. JACS 123 (2001) 3171-3172
17. Allardyce C.S., Dyson P.J., Coffey J., and Johnson N. Determination of drug binding sites to proteins by electrospray ionization mass spectrometry: The interaction of cisplatin with transferrin. Rapid Commun. Mass Spectrom. 16 (2002) 933-935
18. Khalaila I., Allardyce C.S., Verma C.S., and Dyson P.J. A mass spectrometric and molecular modelling study of cisplatin binding to transferrin. Chembiochemistry 6 (2005) 1788-1795
19. Hartinger C.G., Ang W.H., Casini A., Messori L., Keppler B.K., and Dyson P.J. Mass spectrometric analysis of ubiquitin-platinum interactions of leading anticancer drugs: MALDI versus ESI. J. Anal. At. Spectrom. 22 (2007) 960-967
20. Hartinger C.G., Tsybin Y.O., Fuchser J., and Dyson P.J. Characterization of platinum anticancer drug protein-binding sites using a top-down mass spectrometric approach. Inorg. Chem. 47 (2008) 17-19
21. Bushnell G., Louie G., and Brayer G. High-resolution three-dimensional structure of horse heart cytochrome c. Mol. Biol. 214 (1990) 585-595
22. Yang G., Miao R., Jin C., Mei Y., Tang H., Hong J., Guo Z., and Zhu L. Determination of binding sites in carboplatin-bound cytochrome c using electrospray ionization mass spectrometry and tandem mass spectrometry. J. Mass. Spectrom. 40 (2005) 1005-1016
23. Casini A., Gabbiani C., Mastrobuoni G., Messori L., Moneti G., and Pieraccini G. Exploring metallodrug-protein interactions by ESI mass spectrometry: The reaction of anticancer platinum drugs with horse heart. cytochrome c. Chem. Med. Chem. 1 (2006) 413-417
24. Casini A., Gabbiani C., Mastrobuoni G., Pellicani R.Z., Intini F.P., Arnesano F., Natile G., Moneti G., Francese S., and Messori L. Insights into the molecular mechanisms of protein platination from a case study: The reaction of anticancer platinum(II) iminoethers with horse heart. cytochrome c. Biochemistry 46 (2007) 12220-12230
25. Marshall A.G., Hendrickson C.L., and Jackson G.S. Fourier transform ion cyclotron resonance mass spectrometry: A primer. Mass Spectrom. Rev. 17 (1998) 1-35
26. Medzihradszky K.F. Peptide sequence analysis. Methods Enzymol. 402 (2005) 209-244
27. Tang L., and Kebarle P. Dependence of ion intensity in electrospray mass spectrometry on the concentration of the analytes in the electrosprayed solution. Anal. Chem. 65 (1993) 3654-3668
28. Gabelica V., Galic N., Rosu F., Houssier C., and Pauw E.D. Influence of response factors on determining equilibrium association constants of noncovalent complexes by electrospray ionization mass spectrometry. J. Mass Spectrom. 38 (2003) 491-501
29. Zhang Z., and Marshall A.G. A universal algorithm for fast and automated charge state deconvolution of electrospray mass-to-charge ratio spectra. J. Am. Soc. Mass Spectrom. 9 (1998) 225-233
30. Qi P.X., Urbauer J.L., Fuentes E.J., Leopold M.F., and Wand A.J. Structural water in oxidized and reduced horse heart. cytochrome c. Nature Struct. Biol. 1 (1994) 378-382
31. Medzihradszky K.F. In-solution digestion of proteins for mass spectrometry. Methods Enzymol. 405 (2005) 50-65